The invention relates to a novel fish virus, indicated to be a Totivirus, which causes mortality in fish, and to methods of detecting said virus in fish, and related uses.
C12Q 1/70 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir des virus ou des bactériophages
A fish handling unit for processing live fish is provided. Such fish handling unit includes an inspection system configured to inspect a plurality of live fish. A conveyor assembly transports the live fish to the inspection system. At least one robotic cell is in communication with the inspection system. The robotic cell has a controller configured to control operation thereof. An end effector is operably engaged with the robotic cell. The end effector interacts with the live fish moving along the conveyor assembly, based on information determined by the inspection system and received by the controller. The end effector may optionally be an integrated gripper and injection assembly capable of orientation and injection of the live fish. Associated devices and methods are also provided.
The invention relates to a novel fish virus, indicated to be a Coronavirus, which causes mortality in fish, and to methods of detecting said virus in fish, and related uses.
The present invention describes vaccine compositions for treatment and/or prevention against sea lice infestation in salmon. The present invention further describes nucleic acids, host cells, vectors and methods of using said vaccine for the prevention and/or treatment of sea lice infestation in salmon.
A01K 61/13 - Prévention ou traitement des maladies des poissons
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
A61K 39/00 - Préparations médicinales contenant des antigènes ou des anticorps
A61K 39/39 - Préparations médicinales contenant des antigènes ou des anticorps caractérisées par les additifs immunostimulants, p. ex. par les adjuvants chimiques
A61P 33/14 - Antiparasites externes, p. ex. antiscabieux
The invention relates to a novel fish virus, indicated to be a Totivirus, which causes mortality in fish, and to methods of detecting said virus in fish, and related uses.
The invention relates to a novel fish virus, indicated to be a Coronavirus, which causes mortality in fish, and to methods of detecting said virus in fish, and related uses.
C12N 15/50 - Coronaviridae, p. ex. virus de la bronchite infectieuse, virus de la gastro-entérite transmissible
C12N 7/00 - Virus, p. ex. bactériophagesCompositions les contenantLeur préparation ou purification
C12Q 1/68 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir des acides nucléiques
C07K 14/165 - Coronaviridae, p. ex. virus de la bronchite infectieuse aviaire
C07K 16/08 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant de virus
A61K 39/215 - Coronaviridae, p. ex. virus de la bronchite infectieuse aviaire
C12N 15/113 - Acides nucléiques non codants modulant l'expression des gènes, p. ex. oligonucléotides anti-sens
21.
Piscine myocarditis virus-like particles and methods of use thereof
Use of milbemycin oxime for controlling a parasitic infestation on fish from sea lice comprising immersion of fish in water containing a therapeutically effective amount of milbemycin oxime. Compositions comprising milbemycin oxime and methods of using said compositions to treat fish are also contemplated.
The present invention describes vaccine compositions for treatment and/or prevention against sea lice infestation in salmon. The present invention further describes nucleic acids, host cells, vectors and methods of using said vaccine for the prevention and/or treatment of sea lice infestation in salmon.
A01K 61/13 - Prévention ou traitement des maladies des poissons
A61K 39/00 - Préparations médicinales contenant des antigènes ou des anticorps
A61P 33/14 - Antiparasites externes, p. ex. antiscabieux
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
A61K 39/39 - Préparations médicinales contenant des antigènes ou des anticorps caractérisées par les additifs immunostimulants, p. ex. par les adjuvants chimiques
A01N 63/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux, contenant des micro-organismes, des virus, des champignons microscopiques, des animaux ou des substances produites par, ou obtenues à partir de micro-organismes, de virus, de champignons microscopiques ou d'animaux, p. ex. enzymes ou produits de fermentation
A01N 65/00 - Biocides, produits repoussant ou attirant les animaux nuisibles, ou régulateurs de croissance des végétaux contenant du matériel provenant d'algues, de lichens, de bryophytes, de champignons multicellulaires ou de plantes, ou leurs extraits
A61K 48/00 - Préparations médicinales contenant du matériel génétique qui est introduit dans des cellules du corps vivant pour traiter des maladies génétiquesThérapie génique
A61K 45/00 - Préparations médicinales contenant des ingrédients actifs non prévus dans les groupes
A61K 39/385 - Haptènes ou antigènes, liés à des supports
A61K 47/00 - Préparations médicinales caractérisées par les ingrédients non actifs utilisés, p. ex. les supports ou les additifs inertesAgents de ciblage ou de modification chimiquement liés à l’ingrédient actif
A fish handling unit (500) for processing live fish (1) is provided. Such fish handling unit (500) includes an inspection system (600) configured to inspect a plurality of live fish (1). A conveyor assembly (550) transports the live fish (1) to the inspection system (600). At least one robotic cell (510) is in communication with the inspection system (600). The robotic cell (510) has a controller configured to control operation thereof. An end effector (800) is operably engaged with the robotic cell (510). The end effector (800) interacts with the live fish (1) moving along the conveyor assembly (550), based on information determined by the inspection system (600) and received by the controller. The end effector (800) may optionally be an integrated gripper and injection assembly (850) capable of orientation and injection of the live fish (1). Associated devices and methods are also provided.
A fish handling unit for processing live fish is provided. Such fish handling unit includes an inspection system configured to inspect a plurality of live fish. A conveyor assembly transports the live fish to the inspection system. At least one robotic cell is in communication with the inspection system. The robotic cell has a controller configured to control operation thereof. An end effector is operably engaged with the robotic cell. The end effector interacts with the live fish moving along the conveyor assembly, based on information determined by the inspection system and received by the controller. The end effector may optionally be an integrated gripper and injection assembly capable of orientation and injection of the live fish. Associated devices and methods are also provided.
The present invention describes vaccine compositions for treatment and/or prevention against sea lice infestation in salmon. The present invention further describes nucleic acids, host cells, vectors and methods of using said vaccine for the prevention and/or treatment of sea lice infestation in salmon.
42 - Services scientifiques, technologiques et industriels, recherche et conception
44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.
Produits et services
Aquaculture vaccination devices. Scientific and technological services and research and development related thereto; industrial analysis and research. Veterinary services.
42 - Services scientifiques, technologiques et industriels, recherche et conception
44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.
Produits et services
Aquaculture vaccination devices. Scientific and technological services and research and development related thereto; industrial analysis and research. Veterinary services.
The present invention relates to an attenuated Piscirickettsia salmonis bacterium. The bacterium comprises mutations in the amino acid sequence of each of the rpoD, FecR, ATP-grasp domain protein, and FtsH gene products. The invention also relates to vaccines comprising the attenuated Piscirickettsia salmonis bacterium that are useful for the prevention of microbial pathogenesis. In addition, the invention relates to methods for the preparation of attenuated Piscirickettsia salmonis bacteria, and vaccines comprising such bacteria.
A method of reducing the concentration of an active pharmaceutical ingredient (API) water is disclosed. The API is a parasiticide and the method comprises filtering the water using a filter having a pore size in the range of 0.1-7 μm.
A parasiticide formulation is provided. The formulation is not toxic to fish when administered by intraperitoneal injection. The formulation is a homogeneous non-aqueous parasiticide solution. The formulation comprises: (a) a hydrophilic polymer; and/ or, (b) a non-aqueous polar solvent, present in the formulation an amount of 5-40% by weight, and a solubilizer.
09 - Appareils et instruments scientifiques et électriques
42 - Services scientifiques, technologiques et industriels, recherche et conception
44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.
Produits et services
Computer software; computer software downloadable from the
internet; computer databases; electronic databases; none of
the aforesaid goods relating to security systems, burglar
alarms, motion detectors and software products related
thereto; none of the aforementioned goods related to real
estate software and real estate. Scientific and technological services and research and
design relating thereto; scientific and technological
services and research relating to aquaculture; industrial
analysis and research services; consultancy services
relating to research in the field of environmental
protection; quality control; consultancy services relating
to quality control; environmental impact, disease management
and process auditing of fish farms; quality control services
relating to fish farms; database design; database
development; none of the foregoing services related or
directed to security systems, burglar alarms or motion
detectors; none of the aforementioned services related to
real estate software and real estate. Veterinary services; clinical veterinary services; hygienic
care for animals; aquaculture consultancy services.
The present disclosure relates to the field of aquaculture, farmed fish and the occurrence of disease in farmed fish. More particularly, the present disclosure provides means for preparing large amounts of an orthoreovirus, such as piscine reovirus (PRV), by ex vivo propagation in nucleated erythrocytes. The present document also provides means for preparing vaccine compositions comprising orthoreovirus.
C12N 7/00 - Virus, p. ex. bactériophagesCompositions les contenantLeur préparation ou purification
C12Q 1/70 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir des virus ou des bactériophages
G01N 33/569 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet pour micro-organismes, p. ex. protozoaires, bactéries, virus
Providing access to computer databases Database management; computerized database management services; compilation of computer databases; updating and maintenance of data in computer databases
09 - Appareils et instruments scientifiques et électriques
35 - Publicité; Affaires commerciales
42 - Services scientifiques, technologiques et industriels, recherche et conception
44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.
Produits et services
(1) Computer software and integrated databases, including software downloadable from the Internet, for use in the fields of aquaculture, agriculture and food supply chain management, providing the functions of: data gathering and analysis, auditing and benchmarking standards of animal welfare and health, ordering aquaculture diagnostics services, analysing data relating to aquaculture diagnostics services, communicating the results of aquaculture diagnostics services, real time environmental data monitoring, real time monitoring of equipment used in aquaculture and agriculture, and monitoring and analysis of carbon dioxide footprints of businesses and operations in agriculture and aquaculture. (1) Scientific and technological consulting services relating to aquaculture, agriculture, food chain management and food chain auditing, and research and design relating thereto; scientific and technological consulting services and research relating to aquaculture; industrial analysis and research services relating to aquaculture, agriculture, food chain management and food chain auditing; quality control services in the fields of aquaculture, agriculture, food chain management and food chain auditing; consultancy services relating to quality control; auditing of fish farms; database design; database development; none of the foregoing services related or directed to security systems, burglar alarms or motion detectors; none of the aforementioned services related to real estate software and real estate; aquaculture consultancy services.
(2) Scientific and technological consulting services and research relating to agriculture; Agriculture consultancy services.
44.
IMMUNOGENIC COMPOSITION AGAINST AEROMONAS HYDROPHILA
It is an objective of the present invention to provide a composition, e.g. in form of an immunogenic composition or a vaccine for the protection of fish against infection from Aeromonas hydrophila. The present invention furthermore relates to a combination of immunogenic amounts of two highly virulent Aeromonas hydrophila strains, one belonging to biotype A and one belonging to biotype B, e.g. in an immunogenic composition or in a vaccine, in order to providing efficient prophylactic protection of against infection caused by Aeromonas hydrophila.
09 - Appareils et instruments scientifiques et électriques
35 - Publicité; Affaires commerciales
38 - Services de télécommunications
42 - Services scientifiques, technologiques et industriels, recherche et conception
44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.
Produits et services
Computer software; computer software downloadable from the internet; computer databases; electronic databases; none of the aforesaid goods relating to security systems, burglar alarms, motion detectors and software products related thereto; none of the aforementioned goods related to real estate software and real estate. Database management; computerised database management services; compilation of computer databases; updating and maintenance of data in computer databases; none of the foregoing services related or directed to security systems, burglar alarms or motion detectors; none of the aforementioned services related to real estate software and real estate. Providing access to computer databases; none of the foregoing services related or directed to security systems, burglar alarms or motion detectors; none of the aforementioned services related to real estate software and real estate. Scientific and technological services and research and design relating thereto; scientific and technological services and research relating to aquaculture; industrial analysis and research services; consultancy services relating to research in the field of environmental protection; quality control; consultancy services relating to quality control; auditing of fish farms; database design; database development; none of the foregoing services related or directed to security systems, burglar alarms or motion detectors; none of the aforementioned services related to real estate software and real estate. Veterinary services; clinical veterinary services; hygienic care for animals; aquaculture consultancy services.
The present invention relates to an isolated non-enveloped, positive stranded RNA virus. The invention further relates to an isolated nucleic acid sequence transcribed from the viral genome and to isolated or recombinant amino acid sequences corresponding to proteins encoded by a nucleic acid sequence within an open reading frame in the viral genome. The invention further provides antibodies, nucleic acid sequences, immunogenic compositions and methods of manufacturing such, methods of detecting the virus, and diagnostic kits. Finally, the invention also provides a virus of the invention for use in medicine and use of a virus of the invention in the manufacture of an immunological composition.
The present invention relates to compositions for treatment and prevention of sea lice infestation in fish. In particular, the invention concerns new compositions comprising cyclic monoterpenoid phenols selected from thymol and carvacrol and prodrugs thereof for treatment and prevention of sea lice infections or infestations in fish. Furthermore the present invention relates to the use of at least one cyclic monoterpenoid phenols selected from thymol and carvacrol or prodrugs thereof in the preparation of a composition for treatment of sea lice infection in fish.
The present invention relates to nucleic acid sequences originating from a virus causing cardiomyopathy syndrome (CMS) and the use thereof within veterinary immunology and diagnosis.
C12Q 1/70 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir des virus ou des bactériophages
05 - Produits pharmaceutiques, vétérinaires et hygièniques
42 - Services scientifiques, technologiques et industriels, recherche et conception
44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.
Produits et services
(1) Veterinary preparations for the treatment of diseases in fish, shrimp and other aquatic animals; Vaccines against diseases in fish, shrimp and other aquatic animals. (1) Research and development (for others), quality control, scientific research, bacteriological research, viral research, biological research, all the aforementioned relating to veterinary preparations for the treatment of diseases in fish, shrimp and other aquatic animals and vaccines against diseases in fish, shrimp and other aquatic animals; Industrial analysis services, industrial research services, all the aforementioned relating to veterinary preparations for the treatment of diseases in fish, shrimp and other aquatic animals and vaccines against diseases in fish, shrimp and other aquatic animals; Veterinary services.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
42 - Services scientifiques, technologiques et industriels, recherche et conception
44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.
Produits et services
Veterinary preparations; vaccines; all aforementioned goods for use in aqua culture purposes only. Scientific and technological services and research and design relating thereto; industrial analysis and research services. Veterinary services.
The present invention relates to use of vitamin K3 for treatment of parasitic disease in an individual, such as an animal or human being. In one preferred embodiment vitamin K3 has been found to be effective in the treatment of fish suffering from parasite infestation. The present invention relates to a pharmaceutical composition or a food or feed composition comprising vitamin K3.
The present application provides processes for culturing bacteria belonging to the Piscirickettsia genus, processes for selecting/identifying such bacteria as well as processes for manufacturing vaccines. The invention further provides vaccine compositions and formulations and bacteria that are identified and/or cultured by a process according to the invention.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
Produits et services
(1) Pharmaceutical and veterinary preparations, namely, vaccines against diseases in fish and veterinary preparations for the treatment of diseases in fish.
05 - Produits pharmaceutiques, vétérinaires et hygièniques
29 - Viande, produits laitiers et aliments préparés ou conservés
31 - Produits agricoles; animaux vivants
Produits et services
(1) Potentiated sulfa premix for control of furunculosis in trout and salmon.
(2) Medicinal preparations for the control of bacterial infections and coccidiosis in livestock, poultry, companion animals and aquaculture species.
60.
LIVE FISH PROCESSING SYSTEM, AND ASSOCIATED METHODS
A fish handling unit (500) for processing live fish (1) is provided. Such fish handling unit (500) includes an inspection system (600) configured to inspect a plurality of live fish (1). A conveyor assembly (550) transports the live fish (1) to the inspection system (600). At least one robotic cell (510) is in communication with the inspection system (600). The robotic cell (510) has a controller configured to control operation thereof. An end effector (800) is operably engaged with the robotic cell (510). The end effector (800) interacts with the live fish (1) moving along the conveyor assembly (550), based on information determined by the inspection system (600) and received by the controller. The end effector (800) may optionally be an integrated gripper and injection assembly (850) capable of orientation and injection of the live fish (1). Associated devices and methods are also provided.
The present invention relates to nucleic acid sequences originating from a virus causing cardiomyopathy syndrome (CMS) and the use thereof within veterinary immunology and diagnosis.
C12Q 1/70 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir des virus ou des bactériophages
The present disclosure relates to the field of aquaculture, farmed fish and the occurrence of disease in farmed fish. More particularly, the present disclosure provides means for preparing large amounts of an orthoreovirus, such as piscine reovirus (PRV), by ex vivo propagation in nucleated erythrocytes. The present document also provides means for preparing vaccine compositions comprising orthoreovirus.
C12N 7/00 - Virus, p. ex. bactériophagesCompositions les contenantLeur préparation ou purification
C12Q 1/70 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir des virus ou des bactériophages
G01N 33/569 - Tests immunologiquesTests faisant intervenir la formation de liaisons biospécifiquesMatériaux à cet effet pour micro-organismes, p. ex. protozoaires, bactéries, virus
63.
A NON-AQUEOUS INJECTABLE HEXAFLUMURON FORMULATION FOR TREATING SEA LICE ON FISH
A parasiticide formulation is provided. The formulation is not toxic to fish when administered by intraperitoneal injection. The formulation is a homogeneous non-aqueous parasiticide solution. The formulation comprises: (a) a hydrophilic polymer; and/ or, (b) a non-aqueous polar solvent, present in the formulation an amount of 5-40% by weight, and a solubilizer.
A61K 31/17 - Amides, p. ex. acides hydroxamiques ayant le groupe N-C(O)-N ou N-C(S)-N, p. ex. urée, thiourée, carmustine
A61K 47/08 - Composés organiques, p. ex. hydrocarbures naturels ou synthétiques, polyoléfines, huile minérale, gelée de pétrole ou ozocérite contenant de l'oxygène
A61K 47/10 - AlcoolsPhénolsLeurs sels, p. ex. glycérolPolyéthylène glycols [PEG]PoloxamèresAlkyléthers de PEG/POE
A61K 47/30 - Composés macromoléculaires organiques ou inorganiques, p. ex. polyphosphates inorganiques
A method of reducing the concentration of an active pharmaceutical ingredient (API) water is disclosed. The API is a parasiticide and the method comprises filtering the water using a filter having a pore size in the range of 0.1-7 µm.
The present invention relates to an attenuated Piscirickettsia salmonis bacterium. The bacterium comprises mutations in the amino acid sequence of each of the rpoD, FecR, ATP-grasp domain protein, and FtsH gene products. The invention also relates to vaccines comprising the attenuated Piscirickettsia salmonis bacterium that are useful for the prevention of microbial pathogenesis. In addition, the invention relates to methods for the preparation of attenuated Piscirickettsia salmonis bacteria, and vaccines comprising such bacteria.
The present invention describes vaccine compositions for treatment and/or prevention against sea lice infestation in salmon. The present invention further describes nucleic acids, host cells, vectors and methods of using said vaccine for the prevention and/or treatment of sea lice infestation in salmon.
A61K 39/00 - Préparations médicinales contenant des antigènes ou des anticorps
C07K 14/435 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains
C12N 15/12 - Gènes codant pour des protéines animales
C12N 15/63 - Introduction de matériel génétique étranger utilisant des vecteursVecteurs Utilisation d'hôtes pour ceux-ciRégulation de l'expression
68.
LIVE FISH PROCESSING SYSTEM, AND ASSOCIATED METHODS
A fish handling unit (500) for processing live fish (1) is provided. Such fish handling unit (500) includes an inspection system (600) configured to inspect a plurality of live fish (1). A conveyor assembly (550) transports the live fish (1) to the inspection system (600). At least one robotic cell (510) is in communication with the inspection system (600). The robotic cell (510) has a controller configured to control operation thereof. An end effector (800) is operably engaged with the robotic cell (510). The end effector (800) interacts with the live fish (1) moving along the conveyor assembly (550), based on information determined by the inspection system (600) and received by the controller. The end effector (800) may optionally be an integrated gripper and injection assembly (850) capable of orientation and injection of the live fish (1). Associated devices and methods are also provided.
Abstract The present invention relates to a composition comprising salmonid alphavirus or an antigenic and/or immunogenic material derived thereof, combined with one or more components selected from the group consisting of: a live, attenuated or killed bacterium, a virus other than salmonid alphavirus, said virus preferably being attenuated or inactivated, a fungus, a parasite; and an antigenic and/or immunogenic material derived from any of these components. The invention further relates to a dosage form and a vaccine comprising the said composition and the invention provides for use of the composition in medicine. Also, the invention relates to a method of manufacturing a composition or a vaccine as described above, and to a method of improving a polyvalent vaccine, comprising including in the polyvalent vaccine an attenuated or inactivated salmonid alphavirus. = Date Recue/Date Received 2020-08-14
A61P 1/18 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des troubles pancréatiques, p. ex. enzymes pancréatiques
A61P 31/14 - Antiviraux pour le traitement des virus ARN
C07K 14/18 - Togaviridae, p. ex. flavivirus, virus de la peste, virus de la fièvre jaune, virus de l'hépatite C, virus de l'encéphalite japonaise
C12N 7/01 - Virus, p. ex. bactériophages, modifiés par l'introduction de matériel génétique étranger
C12N 7/04 - Inactivation ou atténuationProduction de parties élémentaires de virus
70.
HEART AND SKELETAL MUSCLE INFLAMMATION (HSMI) VIRUS
The present invention relates to an isolated Heart and Skeleton Muscle Inflammation Virus (HSMIV) derived from fish; a live, attenuated or inactivated HSMIV, or parts of it functional for vaccine purposes, a recombinant antigen and vaccine; as well as DNA, cell lines, vaccines, antibodies, methods and uses thereof. The invention may be utilized to prevent and diagnose Heart and Skeleton Muscle Inflammation (HSMI) in fish.
The present invention provides a fish virus, which when injected into a fish has the ability to introduce the symptoms and disease of Cardiomyopathy Syndrome (CMS). Further, a vaccine is provided comprising a virus according to the invention or a component or part of said virus. The invention further provides a method for isolating or producing the virus. The invention further provides use of the virus for the management of diseases in fish.
The present invention relates to a composition comprising salmonid alphavirus or an antigenic and/or immunogenic material derived thereof, combined with one or
more components selected from the group consisting of: a live, attenuated or killed bacterium, a virus other than salmonid alphavirus, said virus preferably being attenuated or inactivated, a fungus, a parasite; and an antigenic and/or
immunogenic material derived from any of these components. The invention further relates to a dosage form and a vaccine comprising the said composition and the invention provides for use of the composition in medicine. Also, the invention relates to a method of manufacturing a composition or a vaccine as described above, and to a method of improving a polyvalent vaccine,
comprising including in the polyvalent vaccine an attenuated or inactivated salmonid alphavirus.
The present application provides processes for culturing bacteria belonging to the Piscirickettsia genus, processes for selecting/identifying such bacteria as well as processes for manufacturing vaccines. The invention further provides vaccine compositions and formulations and bacteria that are identified and/or cultured by a process according to the invention.
The present invention relates to an isolated non-enveloped, positive stranded RNA virus identified in Atlantic salmon in Norway and which is likely to belong to the Caliciviridae family, herein name Salmonid calicivirus. The invention further relates to an isolated nucleic acid sequence transcribed from the viral genome of the Salmonid calicivirus and to isolated or recombinant amino acid sequences corresponding to proteins encoded by a nucleic acid sequence within an open reading frame in the viral genome of the Salmonid calicivirus. The invention further provides antibodies, nucleic acid sequences, immunogenic compositions and methods of manufacturing such, methods of detecting the Salmonid calicivirus, diagnostic kits and vaccines. Finally, the invention also provides the Salmonid calicivirus for use in medicine and use of the Salmonid calicivirus in the manufacture of an immunological composition.
Use of milbemycin oxime for controlling a parasitic infestation on fish from sea lice comprising immersion of fish in water containing a therapeutically effective amount of milbemycin oxime. Compositions comprising milbemycin oxime and methods of using said compositions to treat fish are also contemplated.
The invention relates to a novel fish virus, indicated to be a Totivirus, which causes mortality in fish, and to methods of detecting said virus in fish, and related uses.
The invention relates to a novel fish virus, indicated to be a Coronavirus, which causes mortality in fish, and to methods of detecting said virus in fish, and related uses.
A61K 39/215 - Coronaviridae, p. ex. virus de la bronchite infectieuse aviaire
C07K 14/165 - Coronaviridae, p. ex. virus de la bronchite infectieuse aviaire
C07K 16/08 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant de virus
C12N 7/00 - Virus, p. ex. bactériophagesCompositions les contenantLeur préparation ou purification
C12N 15/113 - Acides nucléiques non codants modulant l'expression des gènes, p. ex. oligonucléotides anti-sens
C12N 15/50 - Coronaviridae, p. ex. virus de la bronchite infectieuse, virus de la gastro-entérite transmissible
C12Q 1/68 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir des acides nucléiques
The present invention describes vaccine compositions for treatment and/or prevention against sea lice infestation in salmon. The present invention further describes nucleic acids, host cells, vectors and methods of using said vaccine for the prevention and/or treatment of sea lice infestation in salmon.
C07K 14/435 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains
C12N 15/12 - Gènes codant pour des protéines animales
C12N 15/63 - Introduction de matériel génétique étranger utilisant des vecteursVecteurs Utilisation d'hôtes pour ceux-ciRégulation de l'expression
